02.02.24 -- Release Testing Of AAV Gene Therapies For Clinical Trials

Optimize your technical transfer process using built-for-purpose, cloud-connected systems and obtain results that translate effectively to other facilities.

Biologics demand continues to grow, but challenges surrounding funding and regulation persist. Review trends shaping the industry and learn why an experienced partner is crucial in today’s market.

Find out why the business case for any therapeutic starts with a CMC developability assessment and why it’s important to understand your end game as early as discovery.

Learn from an industry expert how important it is for companies to be compliant with data integrity and to ensure the trustworthiness and reliability of electronic records.

Learn how a CDMO automatically created a comprehensive batch report model to drive their reporting and speed root cause identification of quality failures with an industrial DataOps software solution.

Learn about environmental monitoring requirements, suitable techniques for environmental monitoring that meet risk assessment needs, typical instrumentation features, and more.

The right CDMO offering integrated services can ease increasingly common CGT manufacturing problems such as scale, raw material access, viral vector production, and quality requirements.

Get the most out of your MES data by asking the right questions and preparing for the future of MES in the biopharma industry.

Explore four common applications of cryopreservation and the science behind selecting the appropriate materials to build single-use solutions that enable cryogenic storage for cell and gene applications.

Find out how a bench-scale bioreactor could pave your way to maximum culture density, better process information, and scale-up/scale-down development.

Learn about an effective cleaning solution that removes DNA from laboratory equipment and materials without the need for bleach.

Evaluate the effect of excipients in the viscosity reduction platform on ultrafiltration processes used to produce a highly concentrated mAb formulation as demonstrated with two filtration methods.